Prevalence and Risk Factors for Major Infections in Patients with Antineutrophil Cytoplasmic Antibody-associated Va… https://t.co/pcYlTL1UP5
RT @Reuma_Online_: Infecciones en #vasculitis ANCA parecen asociarse a mayor actividad, dosis acumulada CYC>8.6gr, #diálisis y leucopenia.…
RT @Reuma_Online_: Infecciones en #vasculitis ANCA parecen asociarse a mayor actividad, dosis acumulada CYC>8.6gr, #diálisis y leucopenia.…
RT @Reuma_Online_: Infecciones en #vasculitis ANCA parecen asociarse a mayor actividad, dosis acumulada CYC>8.6gr, #diálisis y leucopenia.…
RT @Reuma_Online_: Infecciones en #vasculitis ANCA parecen asociarse a mayor actividad, dosis acumulada CYC>8.6gr, #diálisis y leucopenia.…
RT @Reuma_Online_: Infecciones en #vasculitis ANCA parecen asociarse a mayor actividad, dosis acumulada CYC>8.6gr, #diálisis y leucopenia.…
RT @Reuma_Online_: Infecciones en #vasculitis ANCA parecen asociarse a mayor actividad, dosis acumulada CYC>8.6gr, #diálisis y leucopenia.…
RT @Reuma_Online_: Infecciones en #vasculitis ANCA parecen asociarse a mayor actividad, dosis acumulada CYC>8.6gr, #diálisis y leucopenia.…
RT @Reuma_Online_: Infecciones en #vasculitis ANCA parecen asociarse a mayor actividad, dosis acumulada CYC>8.6gr, #diálisis y leucopenia.…
Mira @amarcadia Información de interés sobre #vasculitis
Infecciones en #vasculitis ANCA parecen asociarse a mayor actividad, dosis acumulada CYC>8.6gr, #diálisis y leucopenia. La leucopenia fue el único factor independientemente asociado a oportunistas. https://t.co/nibbZOK99I
132 pacientes con #vasculitis ANCA las infecciones + frecuentes fueron respiratorias inferiores (64%) y urinarias (11%). Oportunistas en 7.4% (44% en 1er año tto y 55% con CYC). https://t.co/nibbZOK99I
RT @vasculitides: Prevalence and Risk Factors for Major Infections In Patients with Anca-associated Vasculitis. Influence on The Disease Ou…
RT @vasculitides: Prevalence and Risk Factors for Major Infections In Patients with Anca-associated Vasculitis. Influence on The Disease Ou…
More motivation to identify biomarkers to guide the fine balance between disease control and risks of immunosuppression. Evolution of steroid minimizing regimens will also likely have a big impact here.
RT @vasculitides: Prevalence and Risk Factors for Major Infections In Patients with Anca-associated Vasculitis. Influence on The Disease Ou…
Comentaris d’aquest compte de TW de l’article del Dr Garcia-Vives, Dr @fmartinezvalle i @SolansRoser de HUVH.
RT @vasculitides: Prevalence and Risk Factors for Major Infections In Patients with Anca-associated Vasculitis. Influence on The Disease Ou…
RT @vasculitides: Prevalence and Risk Factors for Major Infections In Patients with Anca-associated Vasculitis. Influence on The Disease Ou…
Prevalence and Risk Factors for Major Infections In Patients with Anca-associated Vasculitis. Influence on The Disease Outcome | The Journal of Rheumatology https://t.co/n5URhuMnXS
Prevalence and Risk Factors for Major Infections In Patients with Anca-associated Vasculitis. Influence on The Disease Outcome. - PubMed - NCBI https://t.co/3QAduEqSod
Prevalence and Risk Factors for Major Infections In Patients with Anca-associated Vasculitis. Influence on The Disease Outcome. - PubMed - NCBI https://t.co/VMgFpXQjcP #hvhebron #medint @jrheum
Prevalence and Risk Factors for Major Infections In Patients with Anca-associated Vasculitis. Influence on The Disease Outcome. https://t.co/wpkxyIHAq2